Photonic nanoparticles: emerging theranostics in cancer treatment.
Seyed Hossein ShahcheraghiSeyed Hadi ShahcheraghiMarzieh LotfiMalihe LotfiSeyed Hossein KhaleghinejadZara M TambuwalaVijay MishraYachana MishraÃngel Serrano-ArocaAlaa A A AljabaliMohamed El-TananiGowhar A NaikooSai Raghuveer ChavaNitin B CharbeShivani BhartiSaravana Kumar JaganathanRohit GoyalPoonam NegiMurtaza M TambuwalaOladipo FolorunsoPublished in: Therapeutic delivery (2023)
This review explores the potential of photonic nanoparticles for cancer theranostics. Photonic nanoparticles offer unique properties and photonics capabilities that make them promising materials for cancer treatment, particularly in the presence of near-infrared light. However, the size of the particles is crucial to their absorption of near-infrared light and therapeutic potential. The limitations and challenges associated with the clinical use of photonic nanoparticles, such as toxicity, immune system clearance, and targeted delivery to the tumor are also discussed. Researchers are investigating strategies such as surface modification, biodegradable nanoparticles, and targeting strategies to improve biocompatibility and accumulation in the tumor. Ongoing research suggests that photonic nanoparticles have potential for cancer theranostics, further investigation and development are necessary for clinical use.